Fentanyl Enhances Hepatotoxicity of Paclitaxel via Inhibition of CYP3A4 and ABCB1 Transport Activity in Mice

Abstract

Fentanyl, a potent opioid analgesic that is used to treat cancer pain, is commonly administered with paclitaxel in advanced tumors. However, the effect of fentanyl on the hepatotoxicity of paclitaxel and its potential mechanism of action is not well studied. The purpose of this study was to investigate the effect of fentanyl on the hepatotoxicity of paclitaxel and its potential mechanisms of action. Pharmacokinetic parameters of paclitaxel were tested using reversed phase high-performance liquid chromatography (RP-HPLC). Aspartate transaminase (AST), alanine aminotransferase (ALT), and mouse liver histopathology were examined. Moreover, the cytotoxicity of anti-carcinogens was examined using 1-(4, 5-dimethylthiazol-2-yl)-3,5-diphenylformazan (MTT), and the intracellular accumulation of doxorubicin and rhodamine 123 was detected by flow cytometry. Furthermore, the expression of ABCB1 and the activity of ABCB1 ATPase and CYP3A4 were also examined. In this study, the co-administration of fentanyl and paclitaxel prolonged the half-life (t1/2) of paclitaxel from 1.455 hours to 2.344 hours and decreased the clearance (CL) from 10.997 ml/h to 7.014 ml/h in mice. Fentanyl significantly increased the levels of ALT in mice to 88.2 U/L, which is more than 2-fold higher than the level detected in the control group, and it increased the histological damage in mouse livers. Furthermore, fentanyl enhanced the cytotoxicity of anti-carcinogens that are ABCB1 substrates and increased the accumulation of doxorubicin and rhodamine 123. Additionally, fentanyl stimulated ABCB1 ATPase activity and inhibited CYP3A4 activity in the liver microsomes of mice. Our study indicates that the obvious hepatotoxicity during this co-administration was due to the inhibition of CYP3A4 activity and ABCB1 transport activity. These findings suggested that the accumulation-induced hepatotoxicity of paclitaxel when it is combined with fentanyl should be avoided.

Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma

“…The small GTPases Cdc-42 and Rho-A, in concert with MT1-MMP and MMP-9, are the molecular effectors mediating the pro-invasive functions promoted by S100A4 nuclearization. Bearing in mind the potential toxic effects of PTX in patients with overt cirrhosis and cholestasis (36), these mechanisms represents a promising therapeutic target aimed at preventing metastatic dissemination after detection of the tumor.…”

Pain Management in Patients with Multiple Myeloma: An Update

“…Regarding opioids, CYP3A4 is involved in the metabolism of oxycodone (N-demethylation to inactive noroxycodone) [59] and fentanyl. Fentanyl may inhibit the activity of CYP3A4, resulting in increased bioavailability and toxicity of chemotherapeutic agents, e.g., paclitaxel [60]. The same effect could be potentially observed in MM patients using bortezomib; however, clinical data on pharmacological interactions between opioids and bortezomib are not available to date.…”

Tolerance, Variability and Pharmacokinetics of Albumin-Bound Paclitaxel in Chinese Breast Cancer Patients

“…2 ; however, none of the patients was taking any such concomitant drug in these studies. Thus, we speculate that a gene polymorphism of CYP could have affected the metabolic capability, which leads to higher clearance and ultimately lower exposure of unbound paclitaxel (Hendrikx et al, 2013 ; Frederiks et al, 2015 ; Xie et al, 2015 ).…”